Philip Morris International, Inc. is a leading global tobacco company engaged in the manufacture and sale of cigarettes, tobacco and other nicotine-containing products. The company’s portfolio features some of the best-known brands in the industry, including Marlboro, L&M and Philip Morris, and it has increasingly focused on developing next-generation or reduced-risk products such as heated tobacco units and e-vapor offerings. Philip Morris International operates independently of its former parent, Altria Group, and pursues a strategy aimed at transitioning adult smokers toward less harmful alternatives without compromising on taste or user experience.
Philip Morris International traces its origins to the founding of Philip Morris & Co. in London in 1847, and following an initial public offering in 1972, the business eventually became part of Altria Group. In 2008, the company was spun off from Altria to form a separately traded entity headquartered in Stamford, Connecticut. Since then, the company has invested heavily in research and development through its subsidiary, Philip Morris Products S.A., with the goal of expanding access to noncombustible nicotine offerings across global markets.
The company’s commercial reach extends to more than 180 markets worldwide, with strong positions in Europe, Asia, the Middle East and Latin America. Philip Morris International maintains local manufacturing facilities, distribution networks and partnerships tailored to regional consumer preferences and regulatory environments. By leveraging its global scale, the company seeks to optimize its supply chain and marketing capabilities, while responding to shifting regulatory landscapes and public health considerations.
Under the leadership of Chief Executive Officer Jacek Olczak and a seasoned executive team, Philip Morris International continues to pursue growth through product innovation and portfolio diversification. The company’s commitment to science-based reduced-risk alternatives is supported by extensive clinical and chemical research, aimed at substantiating the health impact of its next-generation offerings. As industry dynamics evolve, Philip Morris International positions itself as a frontrunner in the transition toward a smoke-free future for adult smokers.